Difference between revisions of "Team:Evry/Software/Pipeline"

Line 18: Line 18:
 
             <h1>Pipeline</h1>
 
             <h1>Pipeline</h1>
 
         </div>
 
         </div>
<p class='lead'>A detailed report on the genomics pipeline we created (quality-control, differential expression analysis, data visualisation, variant discovery) can be found <a href="https://static.igem.org/mediawiki/2015/c/c4/Igem_pipeline_description.pdf" _target="_blank">here</a>. After the pipeline, we predict if the genes overexpressed in tumors and mutated can be good candidate antigen by predicting if they will be cleaved by the proteasome and what is their affinity with the CMH-I. </p>
+
<p class='lead'>A detailed report on the genomics pipeline we created (quality-control, differential expression analysis, data visualisation, variant discovery) can be found <a href="https://static.igem.org/mediawiki/2015/c/c4/Igem_pipeline_description.pdf" _target="_blank">here</a>.</p>
 +
 
 +
 
 +
<p class="lead">After idenfication of genes that are both overexpressed and mutated in tumor samples, we want to know if good candidate antigens can be predicted. Read more about the <a href="https://2015.igem.org/Team:Evry/Software/Prediction">prediction step</a>. </p>
 
</div><!-- end .side-body -->
 
</div><!-- end .side-body -->
 
</div> <!-- end .container -->
 
</div> <!-- end .container -->

Revision as of 23:43, 20 November 2015

A detailed report on the genomics pipeline we created (quality-control, differential expression analysis, data visualisation, variant discovery) can be found here.

After idenfication of genes that are both overexpressed and mutated in tumor samples, we want to know if good candidate antigens can be predicted. Read more about the prediction step.

Scroll to top To top